Sep 20, 2024
S1712 finds adding ruxolitinib increases response to TKIs in CML
Sep 13, 2024
Some trial results change the standard of care, while others affirm it. Both are valuable.
Sep 6, 2024
DART shows success in another rare cancer, and DART II is in the works
Aug 30, 2024
That's your PRO Core. Here's a five-year success update.
Aug 23, 2024
A new mentoring program is designed to engage APPs with SWOG and the NCTN
Aug 16, 2024
Aug 9, 2024
Fall group meeting registration opens Tuesday, August 13th